Larvol Delta - Claudin-1-4-6-and-18-isoform-2-as-targets-for-the-treatment-of-cancer-Review

ALE.C04 - Alentis Therap

AZD0901 - AstraZeneca

Vyloy (zolbetuximab) - Astellas

IBI-343 - Innovent Biologics

osemitamab (TST001) - Transcenta

http://www.ncbi.nlm.nih.gov/pubmed/39301632

Masaru Katoh; Masuko Katoh

Sep 21, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next